Debt to EBITDA ratio Analysis of Longboard Pharmaceuticals Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointDebt to EBITDA of LBPH
Dec-23-0.0094Very Poor Debt to EBITDA | Dec-22-0.0081Very Poor Debt to EBITDA | Growth-14.92% |
Debt to EBITDA Analysis of Longboard Pharmaceuticals Inc
| Debt to EBITDA Ratio of LBPH has fallen by -14.92 % Compared to previous Financial Year. |
Other Debt to EBITDA Related Info of LBPH that may interest you.
Longboard Pharmaceuticals Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| LBPH | 18.52 | 19.95 | 7.17 % | Biotechnology |
Defination of Debt to EBITDA
The Debt to EBITDA Ratio is a solvency metric that measures the company's ability to meet its debt obligations by earnings before covering its interest, taxes, depreciation, and amortization. more ..
Debt to EBITDA Related Ratios
| CashFlowFromOperationToDebt | DebtToCapital | EVToEBITDA |
Tsr Stability Index
| No Significant Stability | |
FY - Historical Debt to EBITDA of Longboard Pharmaceuticals Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 |
|---|---|---|---|---|
| Debt to EBITDA | -0.0094 | -0.0081 | -0.0122 | 0 |
| Change | -14.92 % | 33.20 % |
FY Chart of Debt to EBITDA of Longboard Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)